ENHANCED EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-I IN THE FASTED RAT - THE EFFECTS OF INSULIN AND GROWTH-HORMONE ADMINISTRATION

被引:80
作者
MURPHY, LJ
SENEVIRATNE, C
MOREIRA, P
REID, RE
机构
[1] UNIV MANITOBA,FAC MED,DEPT PHYSIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA
[2] UNIV MANITOBA,FAC PHARM,WINNIPEG R3E 0W3,MANITOBA,CANADA
关键词
D O I
10.1210/endo-128-2-689
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of fasting on insulin-like growth factor-binding protein-1 (IGFBP-1) expression was examined in the rat. Food deprivation for a period of 24 h resulted in a 9.5 +/- 2.0-fold increase in hepatic IGFBP-1 mRNA abundance (P < 0.001). An increase in circulating IGFBP-1 in sera from fasted rats was demonstrated by immunoblotting, and an increased abundance of a 30-kDa IGFBP in sera from fasted rats was apparent when [I-125]IGF-I was used in ligand blotting experiments. Refeeding resulted in a prompt decline in hepatic IGFBP-1 mRNA. Administration of insulin (0.5-4 U, ip) to fasted rats resulted in profound hypoglycemia, but either increased or had no significant effect on hepatic IGFBP-1 mRNA abundance. In contrast, administration of human GH (hGH; 100-mu-g, ip) resulted in a prompt decline in hepatic IGFBP-1 mRNA, followed by a late rebound in IGFBP-1 mRNA to levels greater than those in fasted controls. Furthermore, hepatic IGFBP-1 mRNA levels were significantly lower in hGH-treated (100-mu-g every 8 h) food-deprived rats than in saline-treated food-deprived rats (2.25 +/- 1.55- vs. 8.99 +/- 3.80-fold increase; P < 0.005). Similar changes were observed when serum IGFBP-1 was quantitated by immunoblotting. The effects of GH could not be explained by secondary hyperinsulinism, since no significant increase in insulin levels was observed in GH-treated rats. From these observations we conclude the enhanced expression of IGFBP-1 in the food-deprived rat may be a consequence of GH deficiency rather than insulin deficiency.
引用
收藏
页码:689 / 696
页数:8
相关论文
共 30 条
[1]  
BAXER RC, 1987, J CLIN ENDOCR METAB, V65, P432
[2]   THE 25-KILODALTON INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN INHIBITS BOTH BASAL AND IGF-I-MEDIATED GROWTH OF CHICK-EMBRYO PELVIC CARTILAGE INVITRO [J].
BURCH, WM ;
CORREA, J ;
SHIVELY, JE ;
POWELL, DR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01) :173-180
[3]   RADIOIMMUNOASSAY OF A 26,000-DALTON PLASMA INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN - CONTROL BY NUTRITIONAL VARIABLES [J].
BUSBY, WH ;
SNYDER, DK ;
CLEMMONS, DR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (06) :1225-1230
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]   REGULATION OF 70-KILODALTON HEAT-SHOCK-LIKE MESSENGER-RIBONUCLEIC-ACID INVITRO AND INVIVO BY PROLACTIN [J].
DETOLEDO, SM ;
MURPHY, LJ ;
HATTON, TH ;
FRIESEN, HG .
MOLECULAR ENDOCRINOLOGY, 1987, 1 (06) :430-434
[6]   ONTOGENY OF SERUM INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN THE RAT [J].
DONOVAN, SM ;
OH, YM ;
PHAM, H ;
ROSENFELD, RG .
ENDOCRINOLOGY, 1989, 125 (05) :2621-2627
[7]   PARTIAL-PURIFICATION AND CHARACTERIZATION OF A BINDING-PROTEIN FOR INSULIN-LIKE ACTIVITY (ILAS) IN HUMAN AMNIOTIC-FLUID - POSSIBLE INHIBITOR OF INSULIN-LIKE ACTIVITY [J].
DROP, SLS ;
VALIQUETTE, G ;
GUYDA, HJ ;
CORVOL, MT ;
POSNER, BI .
ACTA ENDOCRINOLOGICA, 1979, 90 (03) :505-518
[8]   IMMUNOASSAY OF A SOMATOMEDIN-BINDING PROTEIN FROM HUMAN AMNIOTIC-FLUID - LEVELS IN FETAL, NEONATAL, AND ADULT SERA [J].
DROP, SLS ;
KORTLEVE, DJ ;
GUYDA, HJ ;
POSNER, BI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (05) :908-915
[9]   AN INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING-PROTEIN ENHANCES THE BIOLOGIC RESPONSE TO IGF-I [J].
ELGIN, RG ;
BUSBY, WH ;
CLEMMONS, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3254-3258
[10]   MOLECULAR-FORMS OF SERUM INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEINS IN MAN - RELATIONSHIPS WITH GROWTH-HORMONE AND IGFS AND PHYSIOLOGICAL SIGNIFICANCE [J].
HARDOUIN, S ;
GOURMELEN, M ;
NOGUIEZ, P ;
SEURIN, D ;
ROGHANI, M ;
LEBOUC, Y ;
POVOA, G ;
MERIMEE, TJ ;
HOSSENLOPP, P ;
BINOUX, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (06) :1291-1301